Citigroup’s Fortress Biotech FBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-525
| Closed | -$1.94K | – | 6176 |
|
|
2025
Q3 | $1.94K | Buy |
+525
| New | +$1.33K | ﹤0.01% | 5496 |
|
|
2025
Q2 | – | Sell |
-193
| Closed | -$301 | – | 5729 |
|
|
2025
Q1 | $301 | Sell |
193
-2,896
| -94% | -$5.11K | ﹤0.01% | 5402 |
|
|
2024
Q4 | $6.25K | Sell |
3,089
-9,828
| -76% | -$17.8K | ﹤0.01% | 5435 |
|
|
2024
Q3 | $18.7K | Buy |
+12,917
| New | +$24.6K | ﹤0.01% | 5202 |
|
|
2022
Q3 | – | Sell |
-150
| Closed | -$2K | – | 5975 |
|
|
2022
Q2 | $2K | Sell |
150
-107
| -42% | -$1.59K | ﹤0.01% | 5879 |
|
|
2022
Q1 | $6K | Sell |
257
-1,044
| -80% | -$28.6K | ﹤0.01% | 5747 |
|
|
2021
Q4 | $49K | Buy |
1,301
+709
| +120% | +$31.6K | ﹤0.01% | 5071 |
|
|
2021
Q3 | $29K | Buy |
592
+365
| +161% | +$17.8K | ﹤0.01% | 5047 |
|
|
2021
Q2 | $12K | Sell |
227
-235
| -51% | -$14.2K | ﹤0.01% | 5569 |
|
|
2021
Q1 | $24K | Sell |
462
-530
| -53% | -$29.9K | ﹤0.01% | 5135 |
|
|
2020
Q4 | $47K | Buy |
992
+624
| +170% | +$27K | ﹤0.01% | 6076 |
|
|
2020
Q3 | $22K | Sell |
368
-475
| -56% | -$24.2K | ﹤0.01% | 6120 |
|
|
2020
Q2 | $34K | Sell |
843
-175
| -17% | -$6.5K | ﹤0.01% | 6238 |
|
|
2020
Q1 | $29K | Buy |
1,018
+556
| +120% | +$18.5K | ﹤0.01% | 6432 |
|
|
2019
Q4 | $18K | Sell |
462
-1
| -0.2% | -$26 | ﹤0.01% | 6975 |
|
|
2019
Q3 | $10K | Sell |
463
-92
| -17% | -$2.16K | ﹤0.01% | 7062 |
|
|
2019
Q2 | $12K | Sell |
555
-355
| -39% | -$9.13K | ﹤0.01% | 7246 |
|
|
2019
Q1 | $25K | Buy |
910
+296
| +48% | +$7.76K | ﹤0.01% | 6834 |
|
|
2018
Q4 | $8K | Sell |
614
-25
| -4% | -$417 | ﹤0.01% | 7231 |
|
|
2018
Q3 | $15K | Buy |
639
+313
| +96% | +$10K | ﹤0.01% | 7206 |
|
|
2018
Q2 | $15K | Buy |
326
+51
| +19% | +$2.87K | ﹤0.01% | 7046 |
|
|
2018
Q1 | $19K | Buy |
275
+54
| +24% | +$3.42K | ﹤0.01% | 6759 |
|
|
2017
Q4 | $13K | Buy |
221
+214
| +3,057% | +$12.6K | ﹤0.01% | 6920 |
|
|
2017
Q3 | $0 | Buy |
7
+1
| +17% | +$67 | ﹤0.01% | 7292 |
|
|
2017
Q2 | $0 | Sell |
6
-1
| -14% | -$59 | ﹤0.01% | 7375 |
|
|
2017
Q1 | $0 | Sell |
7
-2,280
| -100% | -$102K | ﹤0.01% | 7221 |
|
|
2016
Q4 | $93K | Buy |
2,287
+2,100
| +1,123% | +$78.5K | ﹤0.01% | 5818 |
|
|
2016
Q3 | $8K | Sell |
187
-42
| -18% | -$1.79K | ﹤0.01% | 6622 |
|
|
2016
Q2 | $9K | Buy |
+229
| New | +$10.7K | ﹤0.01% | 6589 |
|
|
2015
Q3 | – | Sell |
-14
| Closed | -$1K | – | 7466 |
|
|
2015
Q2 | $1K | Sell |
14
-449
| -97% | -$23K | ﹤0.01% | 7289 |
|
|
2015
Q1 | $27K | Sell |
463
-2,340
| -83% | -$97.5K | ﹤0.01% | 5906 |
|
|
2014
Q4 | $102K | Sell |
2,803
-655
| -19% | -$19.3K | ﹤0.01% | 5212 |
|
|
2014
Q3 | $109K | Buy |
3,458
+1,097
| +46% | +$29.1K | ﹤0.01% | 4690 |
|
|
2014
Q2 | $61K | Sell |
2,361
-3,766
| -61% | -$99.3K | ﹤0.01% | 5025 |
|
|
2014
Q1 | $182K | Buy |
6,127
+3,311
| +118% | +$129K | ﹤0.01% | 4420 |
|
|
2013
Q4 | $111K | Buy |
2,816
+2,650
| +1,596% | +$102K | ﹤0.01% | 5169 |
|
|
2013
Q3 | $17K | Buy |
166
+164
| +8,200% | +$20.1K | ﹤0.01% | 5994 |
|
|
2013
Q2 | $0 | Buy |
+2
| New | +$295 | ﹤0.01% | 6755 |
|
Other funds holding FBIO
OM
SF
SAM
SC
Citigroup's FBIO Position: Q4 2025 in Review
Citigroup sold out of Fortress Biotech (FBIO) in Q4 2025, closing a stake of 525 shares — an estimated $1.94K sold.
Citigroup first reported a position in FBIO in Q2 2013 and held it in 38 quarters. The position peaked at $182K in Q1 2014. 51 funds tracked by Wall St. Rank hold FBIO as of Q4 2025.
- Citigroup reported no remaining Fortress Biotech position as of Q4 2025 after selling out during the quarter.
- Citigroup sold 525 Fortress Biotech shares in Q4 2025, an estimated $1.94K.
- Citigroup first reported a position in Fortress Biotech in Q2 2013 and held it in 38 quarters.
- Citigroup's Fortress Biotech position peaked at $182K in Q1 2014.
- 51 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2025.
Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.